Anna Reustle

706 total citations
8 papers, 382 citations indexed

About

Anna Reustle is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Anna Reustle has authored 8 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology. Recurrent topics in Anna Reustle's work include Epigenetics and DNA Methylation (3 papers), Renal cell carcinoma treatment (2 papers) and interferon and immune responses (1 paper). Anna Reustle is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Renal cell carcinoma treatment (2 papers) and interferon and immune responses (1 paper). Anna Reustle collaborates with scholars based in Germany, Spain and United States. Anna Reustle's co-authors include Michael Torzewski, Florian Büttner, Arnulf Stenzl, Steffen Rausch, Jens Bedke, Matthias Schwab, Stefan Winter, Elke Schaeffeler, Stephan Kruck and Marcus Scharpf and has published in prestigious journals such as Journal of Virology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Anna Reustle

8 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Reustle Germany 8 222 90 89 81 49 8 382
Dezhi Li China 13 259 1.2× 62 0.7× 102 1.1× 56 0.7× 50 1.0× 25 425
Jinsen Lu China 13 217 1.0× 68 0.8× 77 0.9× 113 1.4× 35 0.7× 18 445
Changming Wang China 7 205 0.9× 146 1.6× 44 0.5× 68 0.8× 35 0.7× 10 396
Yusheng Li China 11 240 1.1× 65 0.7× 102 1.1× 66 0.8× 39 0.8× 25 452
Yuting Wu China 14 178 0.8× 52 0.6× 60 0.7× 64 0.8× 35 0.7× 33 399
Cui Zhai China 15 276 1.2× 196 2.2× 85 1.0× 80 1.0× 33 0.7× 31 583
Mina Hosseini Iran 9 230 1.0× 32 0.4× 148 1.7× 51 0.6× 118 2.4× 22 409
Jacob Cardenas United States 10 201 0.9× 26 0.3× 79 0.9× 143 1.8× 76 1.6× 15 468
Wenfeng Li China 10 394 1.8× 85 0.9× 113 1.3× 94 1.2× 65 1.3× 20 531

Countries citing papers authored by Anna Reustle

Since Specialization
Citations

This map shows the geographic impact of Anna Reustle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Reustle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Reustle more than expected).

Fields of papers citing papers by Anna Reustle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Reustle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Reustle. The network helps show where Anna Reustle may publish in the future.

Co-authorship network of co-authors of Anna Reustle

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Reustle. A scholar is included among the top collaborators of Anna Reustle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Reustle. Anna Reustle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Reustle, Anna, Ute Hofmann, Viktoria Stühler, et al.. (2022). Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma. Clinical and Translational Medicine. 12(6). e883–e883. 26 indexed citations
2.
Kehrer, Jessica, Claudia Kuss, Amparo Andrés‐Pons, et al.. (2018). Nuclear Pore Complex Components in the Malaria Parasite Plasmodium berghei. Scientific Reports. 8(1). 11249–11249. 16 indexed citations
3.
Schaeffeler, Elke, Florian Büttner, Anna Reustle, et al.. (2018). Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin. European Urology Focus. 5(4). 608–618. 36 indexed citations
4.
Reustle, Anna, Pascale Fisel, Olga Renner, et al.. (2018). Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma. International Journal of Cancer. 143(12). 3181–3193. 41 indexed citations
5.
Reustle, Anna & Michael Torzewski. (2018). Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis. International Journal of Molecular Sciences. 19(12). 3761–3761. 129 indexed citations
6.
Esser‐Nobis, Katharina, Anna Reustle, Philipp Schult, et al.. (2015). DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture. Journal of Virology. 89(20). 10548–10568. 51 indexed citations
7.
Solé, Mar, Anna Fàbrega, Nazaret Cobos-Trigueros, et al.. (2015). In vivoevolution of resistance ofPseudomonas aeruginosastrains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure. Journal of Antimicrobial Chemotherapy. 70(11). 3004–3013. 34 indexed citations
8.
Büttner, Florian, Stefan Winter, Steffen Rausch, et al.. (2015). Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron. European Urology. 68(6). 1016–1020. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026